Juven clinical trials
How each study uses Juven is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Juven
- 8
Studies by the year they started
8 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 8
The University of Texas Health Science Center at San Antonio (1) · Medical College of Wisconsin (1) · Michael C Willey (1) · Radiation Therapy Oncology Group (1) · University of Alabama at Birmingham (1) · M.D. Anderson Cancer Center (1) · Central Arkansas Veterans Healthcare System (1) · University of Iowa (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Juven is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture SurgeryCompletedEarly Phase 1The University of Texas Health Science Center at San AntonioNCT05971173Written as Juven
- Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen AblationCompletedPhase 2Medical College of WisconsinNCT01607879Written as Standard of care ADT + (HMB + arginine + glutamine)
- Trauma Screening and SupplementationCompletedNot applicableMichael C WilleyNCT03658278Written as Juven
- Spine and Tumor Screening and SupplementationWithdrawnNot applicableUniversity of IowaNCT03660540Written as Juven
- Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With CancerCompletedPhase 3Radiation Therapy Oncology GroupNCT00053053Written as Juven
- Multimodal Treatment Strategy for Cancer CachexiaTerminatedNot applicableM.D. Anderson Cancer CenterNCT00625742Written as Juven
- Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB)TerminatedPhase 1Central Arkansas Veterans Healthcare SystemNCT00502372Written as Nutritional Supplement/Amino acids and HMB
- Dietary Supplements and Aging MuscleCompletedNot applicableUniversity of Alabama at BirminghamNCT01057082Written as Juven